EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Obesogenic Dysregulation of Human Periprostatic Adipose Tissue Promotes the Viability of Prostate Cells and Reduces Their Sensitivity to Docetaxel and Cabazitaxel

Mariana Feijó iD, Lara R S Fonseca iD, Gonçalo Catarro iD, Cátia V Vaz, Carlos Rabaça iD, Bruno J Pereira iD, Eugenia Gallardo iD, Endre Kiss-Toth iD, Sara Correia iD, Sílvia Socorro iD

Medical Sciences · 2025

DOI: 10.3390/medsci13040322 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Sciences, 2025. Verfasst von Mariana Feijó und 9 weiteren Autor:innen. Beteiligte Einrichtung: RISE-Health, Department of Chemistry, Faculty of Sciences, University of Beira Interior, Rua Marquês d'Ávila e Bolama, 6201-001 Covilhã, Portugal. Hauptthemen laut MEDLINE: Docetaxel, Taxoids, Adipose Tissue, Prostatic Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, FEDER POCI-COMPETE 2020, Associação Portuguesa de Urologia/Jaba Recordati.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Periprostatic adipose tissue (PPAT) has been shown to play a significant role in prostate cancer (PCa) development and progression. This relationship is further exacerbated by obesity, as PPAT-secreted factors increase PCa aggressiveness and have also been implicated in chemotherapy resistance. Therefore, identifying the molecular mediators of PPAT–prostate interorgan communication and the factors that disrupt this crosstalk is pivotal for better disease management. Obesogens, i.e., endocrine-disrupting chemicals that dysregulate adipose tissue towards an “obese” phenotype, have recently been implicated in disrupting this crosstalk, with an impact on prostate cell fate.

Objectives

This study aimed to investigate whether obesogenic dysregulation of human PPAT secretory activity affects PCa cell viability and their response to docetaxel and cabazitaxel. Methods/Results: Through ex vivo culture of human PPAT and conditioned medium assays, we demonstrated that exposure to the model obesogen tributyltin (TBT) induced an “obese” phenotype in human PPAT, characterised by adipocyte enlargement and increased secretion of leptin and C-C motif chemokine ligand 7. The TBT-treated PPAT secretome enhanced cell viability and decreased the sensitivity of PCa cells to taxanes.

Conclusions

This study provides preliminary evidence that lays the groundwork for future investigations, dissecting the molecular pathways underpinning prostate carcinogenesis and resistance to chemotherapy induced by obesogen-dysregulated PPAT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DocetaxelTaxoidsAdipose TissueProstatic NeoplasmsObesityProstateHumansMaleCell SurvivalCell Line, TumorAntineoplastic AgentsDrug Resistance, Neoplasm

Stichwörter der Autor:innen

cabazitaxeldocetaxelendocrine-disrupting chemicalsobesogensperiprostatic adipose tissueprostate cancer

Substanzen

DocetaxelTaxoidscabazitaxelAntineoplastic Agents

Autor:innen und Institutionen

  • RISE-Health, Department of Chemistry, Faculty of Sciences, University of Beira Interior, Rua Marquês d'Ávila e Bolama, 6201-001 Covilhã, Portugal.
  • RISE-Health, Department of Medical Sciences, Faculty of Health Sciences, University of Beira Interior, Av. Infante D. Henrique, 6200-506 Covilhã, Portugal.
  • Laboratory of Drug-Toxicology, UBImedical, University of Beira Interior, Estrada Municipal 506, 6200-284 Covilhã, Portugal.
  • Instituto Português de Oncologia de Coimbra Francisco Gentil, Av. Bissaya Barreto, 3000-075 Coimbra, Portugal.
  • Faculty of Health Sciences, University of Beira Interior, Av. Infante D. Henrique, 6200-506 Covilhã, Portugal.
  • School of Medicine and Population Health, University of Sheffield, Sheffield S10 2RX, UK.

ORCID-Profile: Mariana Feijó, Lara R S Fonseca, Gonçalo Catarro, Carlos Rabaça, Bruno J Pereira, Eugenia Gallardo, Endre Kiss-Toth, Sara Correia, Sílvia Socorro

Förderung

  • Fundação para a Ciência e Tecnologia
  • FEDER POCI-COMPETE 2020
  • Associação Portuguesa de Urologia/Jaba Recordati
  • FEDER funds through the POCI-COMPETE 2020—Operational Programme Competitiveness and Internationalisation in Axis I—Strengthening research, technological develo…
  • National Funds by FCT-Foundation for Science and Technology, Portugal

Zitieren

APA

Feijó, M., Fonseca, L. R. S., Catarro, G., Vaz, C. V., Rabaça, C., Pereira, B. J., Gallardo, E., Kiss-Toth, E., Correia, S., & Socorro, S. (2025). Obesogenic Dysregulation of Human Periprostatic Adipose Tissue Promotes the Viability of Prostate Cells and Reduces Their Sensitivity to Docetaxel and Cabazitaxel. Medical Sciences. https://doi.org/10.3390/medsci13040322

Vancouver

Feijó M, Fonseca LRS, Catarro G, Vaz CV, Rabaça C, Pereira BJ, et al. Obesogenic Dysregulation of Human Periprostatic Adipose Tissue Promotes the Viability of Prostate Cells and Reduces Their Sensitivity to Docetaxel and Cabazitaxel. Medical Sciences. 2025. doi:10.3390/medsci13040322

BibTeX
@article{Feij2025,
  author = {Feijó, Mariana and Fonseca, Lara R S and Catarro, Gonçalo and Vaz, Cátia V and Rabaça, Carlos and Pereira, Bruno J and Gallardo, Eugenia and Kiss-Toth, Endre and Correia, Sara and Socorro, Sílvia},
  title = {Obesogenic Dysregulation of Human Periprostatic Adipose Tissue Promotes the Viability of Prostate Cells and Reduces Their Sensitivity to Docetaxel and Cabazitaxel},
  journal = {Medical Sciences},
  year = {2025},
  doi = {10.3390/medsci13040322}
}
Kostenlos starten →